| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 37, 809-814, Copyright © 1991 by American Association for Clinical Chemistry
K Spencer
Department of Clinical Biochemistry, Oldchurch Hospital, Essex, U.K.
In this study I investigated the analytical and clinical performance of the measurement of the free beta-subunit of choriogonadotropin (hCG) in normal pregnancies and in pregnancies affected by Down's syndrome. Free beta-hCG in maternal serum has been shown to be increased in Down's syndrome-affected pregnancies and is proportionally increased in more cases than is total hCG. This study confirms previous findings of low concentrations of unconjugated estriol and alpha-fetoprotein in maternal serum in Down's syndrome-affected pregnancies. Using a multivariate risk analysis of maternal age and concentrations of alpha- fetoprotein, unconjugated estriol, and hCG in maternal serum, I determined that, at a risk cutoff value of 1 in 300, 52% of Down's cases could be detected with total hCG in the calculation, compared with 66% with the free beta-hCG concentration. The false-positive rate was 5.9% in both cases. Therefore, free beta-hCG can be used effectively in a screening program for Down's syndrome; however, further studies are required to ascertain whether the measurement of free beta-hCG has any advantages over the use of total hCG for detecting Down's syndrome.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Reis, D. D'Antona, and F. Petraglia Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy Endocr. Rev., April 1, 2002; 23(2): 230 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T M Reynolds Down's syndrome screening: a controversial test, with more controversy to come! J. Clin. Pathol., December 1, 2000; 53(12): 893 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Couzinet, J. Pantel, P. Chanson, J. Young, S. Brailly, I. T. Huhtaniemi, J.-M. Bidart, and G. Schaison Measurement of Plasma Free Luteinizing Hormone {beta}-Subunit in Women J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2293 - 2298. [Abstract] [Full Text]
|
|
|
|
|
|
P. Chanson, J. Pantel, J. Young, B. Couzinet, J.-M. Bidart, and G. Schaison Free Luteinizing-Hormone Beta-Subunit in Normal Subjects and Patients with Pituitary Adenomas J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1397 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Aitken, E. M. Wallace, J. A. Crossley, I. A. Swanston, Y. van Pareren, M. van Maarle, N. P. Groome, J. N. Macri, and J. M. Connor Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy N. Engl. J. Med., May 9, 1996; 334(19): 1231 - 1236. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
